Clinical Trial Update: Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

View source ↗

Summary

This clinical trial investigates cabozantinib as monotherapy or in combination with nivolumab for first-line treatment of advanced or metastatic renal cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma Advanced
• Renal Cell Carcinoma Metastatic

Drugs mentioned

• cabozantinib (cabozantinib)
• nivolumab (nivolumab)

Snippet

Sponsor: Ipsen | Conditions: Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Status: ACTIVE_NOT_RECRUITING